These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 29740685
21. Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study. Italia KY, Jijina FF, Merchant R, Panjwani S, Nadkarni AH, Sawant PM, Nair SB, Ghosh K, Colah RB. J Clin Pathol; 2010 Feb; 63(2):147-50. PubMed ID: 20154037 [Abstract] [Full Text] [Related]
22. Clinical, hematological and molecular features in Thais with beta-Malay/beta-thalassemia and beta-Malay/HbE. Laosombat V, Wongchanchailert M, Sattayesevana B, Nopparatana C. Southeast Asian J Trop Med Public Health; 1997 Feb; 28 Suppl 3():106-9. PubMed ID: 9640610 [Abstract] [Full Text] [Related]
23. Implication of globin gene expression, hemoglobin F and hemoglobin E levels on β-thalassemia/Hb E disease severity. Siriworadechkul S, Jindadamrongwech S, Chuncharunee S, Aupparakkitanon S. Ann Clin Lab Sci; 2014 Feb; 44(4):437-42. PubMed ID: 25361929 [Abstract] [Full Text] [Related]
24. Spectrum of Adrenal Dysfunction in Hemoglobin E/Beta Thalassemia. Singha A, Mukhopadhyay P, Ghosh S. J Clin Endocrinol Metab; 2024 Jan 18; 109(2):e562-e568. PubMed ID: 37772731 [Abstract] [Full Text] [Related]
25. Vascular and hemostatic alterations associated with pulmonary hypertension in β-thalassemia hemoglobin E patients receiving regular transfusion and iron chelation. Uaprasert N, Satitthummanid S, Akkawat B, Sutcharitchan P, Rojnuckarin P. Thromb Res; 2019 Feb 18; 174():104-112. PubMed ID: 30584959 [Abstract] [Full Text] [Related]
26. Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules. Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL. Acta Haematol; 2004 Feb 18; 111(4):189-95. PubMed ID: 15153710 [Abstract] [Full Text] [Related]
27. Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with β-thalassemia. Piga A, Perrotta S, Gamberini MR, Voskaridou E, Melpignano A, Filosa A, Caruso V, Pietrangelo A, Longo F, Tartaglione I, Borgna-Pignatti C, Zhang X, Laadem A, Sherman ML, Attie KM. Blood; 2019 Mar 21; 133(12):1279-1289. PubMed ID: 30617198 [Abstract] [Full Text] [Related]
28. Comparison of efficacy and safety of thalidomide vs hydroxyurea in patients with Hb E-β thalassemia - a pilot study from a tertiary care Centre of India. Jain M, Chakrabarti P, Dolai TK, Ghosh P, Mandal PK, Baul SN, De R. Blood Cells Mol Dis; 2021 May 21; 88():102544. PubMed ID: 33610115 [Abstract] [Full Text] [Related]
29. Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years' follow-up in Egypt. El-Beshlawy A, El-Ghamrawy M, EL-Ela MA, Said F, Adolf S, Abdel-Razek AR, Magdy RI, Abdel-Salam A. Ann Hematol; 2014 Dec 21; 93(12):2045-50. PubMed ID: 25062719 [Abstract] [Full Text] [Related]
30. Promising Response to Thalidomide in Symptomatic β-Thalassemia. Yassin AK. Indian J Hematol Blood Transfus; 2020 Apr 21; 36(2):337-341. PubMed ID: 32425386 [Abstract] [Full Text] [Related]
31. Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia. Locatelli F, Lang P, Wall D, Meisel R, Corbacioglu S, Li AM, de la Fuente J, Shah AJ, Carpenter B, Kwiatkowski JL, Mapara M, Liem RI, Cappellini MD, Algeri M, Kattamis A, Sheth S, Grupp S, Handgretinger R, Kohli P, Shi D, Ross L, Bobruff Y, Simard C, Zhang L, Morrow PK, Hobbs WE, Frangoul H, CLIMB THAL-111 Study Group. N Engl J Med; 2024 May 09; 390(18):1663-1676. PubMed ID: 38657265 [Abstract] [Full Text] [Related]
32. Effectiveness of deferiprone in transfusion-independent beta-thalassemia/HbE patients. Akrawinthawong K, Chaowalit N, Chatuparisuth T, Siritanaratkul N. Hematology; 2011 Mar 09; 16(2):113-22. PubMed ID: 21418744 [Abstract] [Full Text] [Related]
33. HbE/β-thalassemia: basis of marked clinical diversity. Olivieri NF, Pakbaz Z, Vichinsky E. Hematol Oncol Clin North Am; 2010 Dec 09; 24(6):1055-70. PubMed ID: 21075280 [Abstract] [Full Text] [Related]
34. Maintenance of elevated fetal hemoglobin levels by decitabine during dose interval treatment of sickle cell anemia. DeSimone J, Koshy M, Dorn L, Lavelle D, Bressler L, Molokie R, Talischy N. Blood; 2002 Jun 01; 99(11):3905-8. PubMed ID: 12010787 [Abstract] [Full Text] [Related]
35. Measurement of HbA₂ by capillary electrophoresis for diagnosing β-thalassemia/HbE disease in patients with low HbF. Prasing W, Pornprasert S. Lab Med; 2014 Jun 01; 45(3):226-30. PubMed ID: 25051074 [Abstract] [Full Text] [Related]
36. Hemoglobin F and hemoglobin E/beta-thalassemia. Rees DC. J Pediatr Hematol Oncol; 2000 Jun 01; 22(6):567-72. PubMed ID: 11132232 [Abstract] [Full Text] [Related]
37. Role of interleukin-3 and signaling pathways on beta-thalassemia/HbE erythroid progenitor cell in culture. Tanyong DI, Winichagoon P, Siripin D, Seevakool W, Fucharoen S. Southeast Asian J Trop Med Public Health; 2007 Sep 01; 38(5):897-903. PubMed ID: 18041309 [Abstract] [Full Text] [Related]
38. Clinico-haematological profile of HbE syndrome in adults and children. Tyagi S, Pati HP, Choudhry VP, Saxena R. Hematology; 2004 Feb 01; 9(1):57-60. PubMed ID: 14965869 [Abstract] [Full Text] [Related]
39. Oxidative instability of hemoglobin E (β26 Glu→Lys) is increased in the presence of free α subunits and reversed by α-hemoglobin stabilizing protein (AHSP): Relevance to HbE/β-thalassemia. Strader MB, Kassa T, Meng F, Wood FB, Hirsch RE, Friedman JM, Alayash AI. Redox Biol; 2016 Aug 01; 8():363-74. PubMed ID: 26995402 [Abstract] [Full Text] [Related]
40. Decreased nitrite levels in erythrocytes of children with β-thalassemia/hemoglobin E. Suvachananonda T, Wankham A, Srihirun S, Tanratana P, Unchern S, Fucharoen S, Chuansumrit A, Sirachainan N, Sibmooh N. Nitric Oxide; 2013 Sep 01; 33():1-5. PubMed ID: 23680525 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]